Browsing by Author "Piñero, Federico."
Now showing items 21-37 of 37
-
The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative.
Bessone, Fernando.; Hernandez, Nelia.; Lucena, Isabel.; Andrade, Raul.; Piñero, Federico.; Mendizabal, Manuel. (MDPI, 2016-02-25)Drug induced liver injury (DILI) is a rare but well recognized serious adverse reaction. Pre-marketing studies may not detect liver injury, and DILI becomes very often apparent after the drug is launched to the market. ... -
LI-RADS 4 or 5 categorization may not be clinically relevant for decision-making processes: A prospective cohort study
Piñero, Federico.; Thompson, Marcos.; Diaz Telli, Federico.; Et al. (Elsevier, 2020-11)Abstract Introduction and objectives: The liver imaging reporting data system (LI-RADS) for hepatocellular carcinoma (HCC) was proposed to standardize and enhance consensus of reporting. However, clinical utility of LI-RADS ... -
Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update.
Bay, Luisa.; Cañero Velasco, Cristina.; Ciocca, Mirta.; Cotti, Andrea.; Cuarterolo, Miriam.; Fainboim, Alejandro.; Piñero, Federico.; et al. (Sociedad Argentina de Pediatría., 2017-06-01)Lysosomal acid lipase deficiency (LAL-D) is still a little recognized genetic disease with significant morbidity and mortality in children and adults. This document provides guidance on when to suspect LAL-D and how to ... -
Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin America.
Piñero, Federico.; Tisi Baña, Matías.; De Ataide, Elaine C.; Hoyos, Sergio.; Marciano, Sebastián.; Varón, Adriana.; Andres, Margarita.; Zerega, Alina.; et al. (John Wiley & Sons A/S, 2016-05-05)BACKGROUND & AIMS: The French alpha-fetoprotein (AFP) model has recently shown superior results compared to Milan criteria (MC) for prediction of hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) ... -
Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin America.
Piñero, Federico.; Tisi Baña, Matías.; Ataide, Elaine C.; Hoyos Duque, Sergio.; Marciano, Sebastián.; Varón, Adriana.; Anders, Margarita.; et al. (Wiley, 2016-11-01)BACKGROUND & AIMS: The French alpha-fetoprotein (AFP) model has recently shown superior results compared to Milan criteria (MC) for prediction of hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) ... -
Liver transplantation for hepatocellular carcinoma: impact of expansion criteria in a multicenter cohort study from a high waitlist mortality region
Piñero, Federico.; Anders, Margarita.; Boin, Ilka.; Et al. (Wiley, 2021-01)Abstract This study aimed to compare liver transplantation (LT) outcomes and evaluate the potential rise in numbers of LT candidates with hepatocellular carcinoma (HCC) of different allocation policies in a high waitlist ... -
Looking for the Best Model to Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation in Latin America.
Piñero, Federico.; Chagas, Aline.; Ilka, Boin. (the American Association for the Study of Liver Diseases, 2019-02-01) -
Predictive models for recurrence risk of hepatocellular carcinoma after liver transplantation: Still an unmet need.
Piñero, Federico.; Carrihlo, Flair.; Silva, Marcelo. (Wiley, 2017-05-01)Recurrence of hepatocellular carcinoma (HCC) after liver transplanta-tion (LT) is a frightening issue. It is considered a systemic advanced stage with poor survival rate from the time of its diagnosis, with few therapeutic ... -
Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission
Mendizabal, Manuel.; Piñero, Federico.; Ridruejo, Ezequiel.; Et al. (Elsevier, 2021-03)Abstract Introduction & objectives: The independent effect of liver biochemistries as a prognostic factor in patients with COVID-19 has not been completely addressed. We aimed to evaluate the prognostic value of abnormal ... -
Recurrence of hepatocellular carcinoma after liver transplantation: Prognostic and predictive factors of survival in a Latin American cohort
Silva, Marcelo.; Piñero, Federico.; Maccali, Claudia.; Et al. (Wiley, 2021-04)Abstract Background & aim: Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) has a poor prognosis, and the adjusted effect of different treatments on post-recurrence survival (PRS) has not been ... -
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study
Piñero, Federico.; Lavarone, Massimo.; Invernizzi, Federica.; Et al. (Wiley, 2021-12)Abstract Safety of regorafenib in hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) has been recently demonstrated. We aimed to assess the survival benefit of regorafenib compared with best ... -
Reply
Mendizabal, Manuel.; Piñero, Federico.; Ridruejo, Ezequiel. (Elsevier, 2021-03) -
Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study
Piñero, Federico.; Costa, Paulo.; Boteon, Yuri.; Hoyos, Sergio.; Anders, Margarita.; Varón, Adriana.; Zerega, Alina.; et al. (Elsevier Espana,, 2018-03-01)Abstract Background and aims: Heterogeneous data has been reported regarding liver transplantation (LT) for hepatocellular carcinoma (HCC) in Latin America. We aimed to describe treatment during waiting list, survival and ... -
Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study.
Piñero, Federico.; Costa, Paulo.; Boteon, Yuri.; Hoyos Duque, Sergio.; Marciano, Sebastián.; Anders, Margarita.; Varón, Adriana.; et al. (Fundación Clínica Médica Sur, A.C., 2018-03-01)Background and aims. Heterogeneous data has been reported regarding liver transplantation (LT) for hepatocellular carcinoma (HCC) in Latin America. We aimed to describe treatment during waiting list, survival and recurrence ... -
Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?
Piñero, Federico.; Rubinstein, Fernando.; Marciano, Sebastián.; Fernández, Nora.; Silva, Jorge.; Zambelo, Yanina.; Anders, Margarita.; et al. (Springer Science+Business Media, LLC, part of Springer Nature, 2019-03-01)Abstract Background: Biannual ultrasound (US) is recommended as the clinical screening tool for hepatocellular carcinoma (HCC). The effectiveness of surveillance according to the place where US is performed has not been ... -
Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma.
Piñero, Federico.; Mendizabal, Manuel.; Ridruejo, Ezequiel.; Herz, Fernando.; Ameigeiras, Beatriz.; Anders, Margarita.; Schinoni, María.; et al. (Wiley, 2019-01-13)Abstract Background & Aims: Data from Europe and North America have been published re‐ garding the risk of developing hepatocellular carcinoma (HCC) after treatment with direct antiviral agents (DAA). We proposed to ... -
Trial eligibility in advanced hepatocellular carcinoma: Does it support clinical practice in underrepresented subgroups?
Piñero, Federico.; Gomes, Leonardo. (Baishideng Publishing Group, 2021-06)Abstract Although hepatocellular carcinoma is considered a highly lethal malignancy, recent therapeutic advances have been achieved during the last 10 years. This scenario resulted in an unprecedented improvement in ...